Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 10/20 | 0.41 |
| ▸ | MAOA | P21397 | 7/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.37 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.37 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 3/20 | 0.37 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4096980 | 0.89 | ALDH1A1 (0.39) | MAOBMAOAKDM1A | |
| SCHEMBL4096847 | 0.87 | KDM1A (0.43) | MAOBMAOAOPRM1OPRK1OPRL1 | |
| SCHEMBL4085436 | 0.83 | KDM1A (0.34) | MAOBMAOAKCNH2EGFRKDM1A | |
| SCHEMBL4082596 | 0.83 | SLC6A2 (0.36) | MAOBMAOA | |
| SCHEMBL4083002 | 0.82 | SLC6A4 (0.41) | KDM1A | |
| SCHEMBL4099398 | 0.76 | SLC6A3 (0.39) | KDM1A | |
| SCHEMBL4087444 | 0.74 | MAOB (0.46) | MAOBMAOAEGFRKDM1A | |
| SCHEMBL4082808 | 0.74 | CCR2 (0.42) | MAOBMAOAOPRM1OPRK1OPRL1 | |
| SCHEMBL15657386 | 0.72 | CFTR (0.45) | MAOBMAOAKCNH2EGFROPRM1 | |
| SCHEMBL16529973 | 0.72 | OPRM1 (0.42) | MAOBMAOAKCNH2OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100512582-C | Light emitting system, light emitting method and chemical substance for light emission | HITACHI CHEMICAL CO LTD (JP) | 2009-07-08 | — | — | CN | disclosed |
| US-20090163743-A1 | LUMINESCENCE SYSTEM, METHOD OF LUMINESCENCE, AND CHEMICAL SUBSTANCE FOR LUMINESCENCE | HOSHI YOUSUKE | 2009-06-25 | — | — | US | disclosed |
| US-20070138945-A1 | Luminescence system, method of luminescence, and chemical substance for luminescence | HITACHI CHIEMICAL CO., LTD., (JP) | 2007-06-21 | — | — | US | disclosed |
| CN-1898995-A | Light emitting system, light emitting method and chemical substance for light emission | HITACHI CHEMICAL CO LTD (JP) | 2007-01-17 | — | — | CN | disclosed |
| US-5631264-A | NEUROLOGICAL DISORDERS | SANOFI WINTHROP, INC. (US) | 1997-05-20 | — | — | US | disclosed |
| US-5554620-A | Substituted 6,11-ethano-6,11-dihydrobenzo[b] quinolizinium salts and compositions and methods of use thereof | STERLING WINTHROP INC. (US) | 1996-09-10 | — | — | US | disclosed |
| EP-0656359-A1 | Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof | STERLING WINTHROP INC. (US) | 1995-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070138945-A1 | Luminescence system, method of luminescence, and chemical substance for luminescence | GLO1, TYR, GUSB | MAOB 65/4885MAOA 75/4885KCNH2 1886/4885 |
| US-20090163743-A1 | LUMINESCENCE SYSTEM, METHOD OF LUMINESCENCE, AND CHEMICAL SUBSTANCE FOR LUMINESCENCE | GLO1, TYR, GUSB | MAOB 65/4885MAOA 75/4885KCNH2 1886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.